Literature DB >> 15528093

Regional patterns of brain metabolites in AIDS dementia complex.

Constantin T Yiannoutsos1, Thomas Ernst, Linda Chang, P Lani Lee, Todd Richards, Christina M Marra, Dieter J Meyerhoff, Jeffrey G Jarvik, Dennis Kolson, Giovanni Schifitto, Ronald J Ellis, Susan Swindells, David M Simpson, Eric N Miller, R Gilberto Gonzalez, Bradford A Navia.   

Abstract

The relationship of the cellular changes in the HIV-infected brain to the onset and progression of AIDS dementia complex (ADC) remains uncertain. We undertook an in vivo proton magnetic resonance spectroscopy (MRS) study and used factor analysis to identify specific cellular and regional brain changes that may serve as metabolic markers of ADC. The ratio of N-acetyl aspartate (NAA), choline (Cho), and myoinositol (MI) over creatine (Cr), markers of neuronal and glial cell metabolism, were measured in the basal ganglia, centrum semiovale, and parietal cortex from 100 subjects with and without ADC. Three metabolic patterns were identified, which we termed "inflammatory" (mainly MI/Cr elevations in all three regions plus Cho/Cr increases in the centrum semiovale and parietal cortex), "basal ganglia" (mostly NAA/Cr and Cho/Cr elevations in the basal ganglia), and "neuronal" (primarily NAA/Cr reductions in the centrum semiovale and the parietal cortex). Logistic regression analysis revealed that, adjusted for age, basal ganglia and neuronal pattern scores were strongly associated with ADC but inflammatory levels were not. We conclude that by using factor analysis, we are able to combine multiple metabolites across brain regions in a biologically plausible manner and construct a predictive model of ADC adjusting for relevant factors such as age.

Entities:  

Mesh:

Year:  2004        PMID: 15528093     DOI: 10.1016/j.neuroimage.2004.07.033

Source DB:  PubMed          Journal:  Neuroimage        ISSN: 1053-8119            Impact factor:   6.556


  45 in total

Review 1.  Brain dysfunction in the era of combination antiretroviral therapy: implications for the treatment of the aging population of HIV-infected individuals.

Authors:  Uraina S Clark; Ronald A Cohen
Journal:  Curr Opin Investig Drugs       Date:  2010-08

2.  Two patterns of cerebral metabolite abnormalities are detected on proton magnetic resonance spectroscopy in HIV-infected subjects commencing antiretroviral therapy.

Authors:  Alan Winston; Chris Duncombe; Patrick C K Li; John M Gill; Stephen J Kerr; Rebekah L Puls; Simon D Taylor-Robinson; Sean Emery; David A Cooper
Journal:  Neuroradiology       Date:  2012-07-07       Impact factor: 2.804

3.  Differential involvement of p38 and JNK MAP kinases in HIV-1 Tat and gp120-induced apoptosis and neurite degeneration in striatal neurons.

Authors:  I N Singh; N El-Hage; M E Campbell; S E Lutz; P E Knapp; A Nath; K F Hauser
Journal:  Neuroscience       Date:  2005-08-19       Impact factor: 3.590

4.  Cerebral metabolite changes prior to and after antiretroviral therapy in primary HIV infection.

Authors:  Andrew C Young; Constantin T Yiannoutsos; Manu Hegde; Evelyn Lee; Julia Peterson; Rudy Walter; Richard W Price; Dieter J Meyerhoff; Serena Spudich
Journal:  Neurology       Date:  2014-09-26       Impact factor: 9.910

5.  Manganese-Enhanced Magnetic Resonance Imaging Reflects Brain Pathology During Progressive HIV-1 Infection of Humanized Mice.

Authors:  Aditya N Bade; Santhi Gorantla; Prasanta K Dash; Edward Makarov; Balasrinivasa R Sajja; Larisa Y Poluektova; Jiangtao Luo; Howard E Gendelman; Michael D Boska; Yutong Liu
Journal:  Mol Neurobiol       Date:  2015-06-11       Impact factor: 5.590

Review 6.  Quantitative proton magnetic resonance spectroscopy and spectroscopic imaging of the brain: a didactic review.

Authors:  Jeffry R Alger
Journal:  Top Magn Reson Imaging       Date:  2010-04

7.  HIV-associated CD4+/CD8+ depletion in infancy is associated with neurometabolic reductions in the basal ganglia at age 5 years despite early antiretroviral therapy.

Authors:  Kenneth K Mbugua; Martha J Holmes; Mark F Cotton; Eva-Maria Ratai; Francesca Little; Aaron T Hess; Els Dobbels; Andre J W Van der Kouwe; Barbara Laughton; Ernesta M Meintjes
Journal:  AIDS       Date:  2016-06-01       Impact factor: 4.177

8.  Aging exacerbates extrapyramidal motor signs in the era of highly active antiretroviral therapy.

Authors:  Victor Valcour; Michael R Watters; Andrew E Williams; Ned Sacktor; Aaron McMurtray; Cecilia Shikuma
Journal:  J Neurovirol       Date:  2008-11-12       Impact factor: 2.643

9.  Progressive cerebral injury in the setting of chronic HIV infection and antiretroviral therapy.

Authors:  Assawin Gongvatana; Jaroslaw Harezlak; Steven Buchthal; Eric Daar; Giovanni Schifitto; Thomas Campbell; Michael Taylor; Elyse Singer; Jeffrey Algers; Jianhui Zhong; Mark Brown; Deborah McMahon; Yuen T So; Deming Mi; Robert Heaton; Kevin Robertson; Constantin Yiannoutsos; Ronald A Cohen; Bradford Navia
Journal:  J Neurovirol       Date:  2013-04-24       Impact factor: 2.643

10.  In vivo proton magnetic resonance spectroscopy reveals region specific metabolic responses to SIV infection in the macaque brain.

Authors:  Eva-Maria Ratai; Sarah J Pilkenton; Jane B Greco; Margaret R Lentz; Jeffrey P Bombardier; Katherine W Turk; Julian He; Chan-Gyu Joo; Vallent Lee; Susan Westmoreland; Elkan Halpern; Andrew A Lackner; R Gilberto González
Journal:  BMC Neurosci       Date:  2009-06-22       Impact factor: 3.288

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.